Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Gendrin

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Ticks and Tick-Borne Diseases|March 26, 2022
Francisella tularensis infection: variable clinical aspects with persistent pulmonary nodules presentation, a case series of human tularemia in Franche-Comté, FranceSouheil Zayet, Laure Frechet, Yousri Ben Abdallah, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
<i>Leclercia adecarboxylata</i> as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility TestingSouheil Zayet, Stephane Lang, Pauline Garnier, et al.
Viruses|November 27, 2021
COVEVOL: Natural Evolution at 6 Months of COVID-19Louise Messin, Marc Puyraveau, Yousri Benabdallah, et al.
Infection|May 16, 2020
Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatientsSouheil Zayet, Timothee Klopfenstein, Julien Mercier, et al.
Viruses|November 25, 2023
Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent PlasmaLéa Da Silva, Timothée Klopfenstein, Vincent Gendrin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patientsTimothée Klopfenstein, Souheil Zayet, Anne Lohse, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 1, 2018
Persistence of schistosomal transmission linked to the Cavu river in southern Corsica since 2013Lauriane Ramalli, Stephen Mulero, Harold Noël, et al.
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
Life (Basel, Switzerland)|July 27, 2022
Asthma and Cacosmia Could Be Predictive Factors of Olfactory Dysfunction Persistence 9 Months after SARS-CoV-2 Infection: The ANOSVID StudyCan Tipirdamaz, Souheil Zayet, Molka Osman, et al.
Journal of Medical Virology|June 7, 2022
Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID studyJulien Mercier, Molka Osman, Kevin Bouiller, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Ticks and Tick-Borne Diseases|March 26, 2022
Francisella tularensis infection: variable clinical aspects with persistent pulmonary nodules presentation, a case series of human tularemia in Franche-Comté, FranceSouheil Zayet, Laure Frechet, Yousri Ben Abdallah, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
<i>Leclercia adecarboxylata</i> as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility TestingSouheil Zayet, Stephane Lang, Pauline Garnier, et al.
Viruses|November 27, 2021
COVEVOL: Natural Evolution at 6 Months of COVID-19Louise Messin, Marc Puyraveau, Yousri Benabdallah, et al.
Infection|May 16, 2020
Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatientsSouheil Zayet, Timothee Klopfenstein, Julien Mercier, et al.
Viruses|November 25, 2023
Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent PlasmaLéa Da Silva, Timothée Klopfenstein, Vincent Gendrin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patientsTimothée Klopfenstein, Souheil Zayet, Anne Lohse, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 1, 2018
Persistence of schistosomal transmission linked to the Cavu river in southern Corsica since 2013Lauriane Ramalli, Stephen Mulero, Harold Noël, et al.
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
Life (Basel, Switzerland)|July 27, 2022
Asthma and Cacosmia Could Be Predictive Factors of Olfactory Dysfunction Persistence 9 Months after SARS-CoV-2 Infection: The ANOSVID StudyCan Tipirdamaz, Souheil Zayet, Molka Osman, et al.
Journal of Medical Virology|June 7, 2022
Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID studyJulien Mercier, Molka Osman, Kevin Bouiller, et al.
Pageof 6